Histocompatibility complex (HLA)

The major histocompatibility complex (MHC) is the cell surface proteins, which are vital for the acquired immune system to identify foreign molecules in vertebrates, which in turn concludes histocompatibility. The chief purpose of MHC molecules is to bind to peptide fragments resulting from pathogens and exhibit them on the cell surface for recognition by the suitable T-cells. A MHC molecule enables the interactions of leukocytes, which are also known as white blood cells (WBCs), these are immune cells, with other leukocytes or with body cells. The MHC defines compatibility of contributors for organ transplant, as well as one's vulnerability to an autoimmune disease via cross reacting immunization. In humans, the MHC is also titled as the human leukocyte antigen (HLA).

    Related Conference of Histocompatibility complex (HLA)

    August 02-03, 2017

    13th European Pathology Congress

    Milan, Italy
    August 23-24 , 2017

    International Conference on Microbial Pathogenesis,Infectious Diseases & Control

    Toronto, Canada
    Avail Upto 21 ACCME Credits
    August 23-24, 2017

    4th World Congress on Breast Pathology and Cancer Diagnosis

    Toronto, Canada [Holiday Inn Toronto International Airport]
    Sep 11-12, 2017

    World Annual Pathologists Congress

    Los Angeles, USA
    November 13-14, 2017

    14th Asia Pacific Pathology Congress

    Osaka, Japan
    November 15-16, 2017

    2nd International Conference on Digital Pathology

    San Antonio, USA
    April 23-24, 2018

    14th International Conference on Pathology

    Orlando, USA
    August 27-28, 2018

    4th International Conference on Cytopathology & Histopathology

    Boston | Massachusetts | USA

    Histocompatibility complex (HLA) Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in